Pdude, maybe AMRN isn't supportive of a Prepare 3 study!? If Pfizer or any other BP buys AMRN, they wouldn't want any 3rd party doing anymore trials. They would want to conduct...and control those trials themselves. For those who believe a BO happens in the next 6 months, that could explain it. Of course PI2 could be a flop, which would also explain it.
Market Data 
Markets 
AI
